MTEK Form 144: Insider Notice to Sell Ordinary Shares

MTEK reported proposed sales of Ordinary shares under employee stock option plans: 3,980 shares and 15,919 shares, each to be sold after cash upon exercise.

Rhea-AI Filing Summary

MTEK reported proposed sales of Ordinary shares under employee stock option plans: 3,980 shares and 15,919 shares, each to be sold after cash upon exercise.

The notice names Oppenheimer & Co. Inc. as the broker and lists 8,104,180 shares outstanding as of 03/05/2026.

Insights

Equity Markets Analyst

Form 144 lists planned sales of option-derived Ordinary shares by holders using cash-on-exercise arrangements.

Two separate option-sale entries are shown: 3,980 and 15,919 Ordinary shares, both tied to Employee Stock Option Plans and designated as "Cash Upon Exercise." The broker named is Oppenheimer & Co. Inc..

These appear as routine insider dispositions reported under applicable rules; reported shares outstanding are 8,104,180 as of 03/05/2026, which provides context for relative scale. Subsequent filings will show actual transactions and timing.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the MTEK Form 144 disclose?

The filing discloses proposed sales of Ordinary shares: 3,980 and 15,919 shares under employee stock option plans, with sales to occur on a cash-upon-exercise basis through a broker.

Who is the broker handling the MTEK share sales?

The filing lists Oppenheimer & Co. Inc. at 85 Broad St., New York, NY as the broker named in the Form 144 notice handling the proposed transactions.

What method is specified for the MTEK securities to be sold?

The securities are identified as arising from Employee Stock Option Plans and designated for sale with the method described as Cash Upon Exercise, per the Form 144 entries.

How many shares outstanding does MTEK report in the excerpt?

The excerpt lists 8,104,180 shares outstanding as of 03/05/2026, provided as context in the Form 144 notice.

Are the proposed MTEK sales completed by the filing?

No completion is shown; the Form 144 records proposed sales tied to option exercises. Actual sale dates and completed transaction details would appear in subsequent filings or confirmations.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/05/2026 - 12:19 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002054654
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Maris Tech Ltd.
SEC File Number	001-41260
Address of Issuer	2 YITZHAK MODAI STREET REHOVOT ISRAEL 7608804
Phone	0097236093609
Name of Person for Whose Account the Securities are To Be Sold	Bussy Nir
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	19899	36415.17	8104180	03/05/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	04/01/2022	Employee Stock Option Plan	From the Issuer			3980	03/05/2026	Cash Upon Exercise
Ordinary	01/15/2024	Employee Stock Option Plan	From the Issuer			15919	03/05/2026	Cash Upon Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	Under a 10b5-1 sale plan adopted on 04/03/2025
Date of Notice	03/05/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	04/03/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Nir Bussy
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)